Quick answer: The hypothalamic-pituitary-adrenal (HPA) axis — the body’s central stress response system — is one of the most dysregulated and least understood systems in modern medicine. Conventional labs check morning cortisol once and declare everything normal, while the DUTCH Complete (Dried Urine Test for Comprehensive Hormones) reveals the full 24-hour cortisol pattern, cortisol metabolites, DHEA-S, sex hormone metabolites, and methylation status in a single test. HPA axis dysregulation affects energy, sleep, immune function, thyroid conversion, blood sugar regulation, and every other hormonal axis in the body.
The adrenal glands sit above the kidneys and produce three categories of hormones: glucocorticoids (cortisol, cortisone), mineralocorticoids (aldosterone), and adrenal androgens (DHEA, DHEA-S, androstenedione). Of these, cortisol and DHEA-S are the most clinically significant for functional medicine assessment, as their dynamic relationship — the cortisol/DHEA ratio — reflects the overall adaptive capacity of the HPA axis and is a more informative aging and stress biomarker than either hormone alone.
This article examines the HPA axis biology, what DUTCH testing reveals that standard serum testing misses, the spectrum of HPA axis dysfunction from acute stress response to chronic hypocortisolism, how the adrenal axis intersects with thyroid, sex hormones, and blood sugar regulation, and the evidence-based interventions for restoring HPA axis resilience.
The HPA Axis: Biology and the Stress Response
The hypothalamic-pituitary-adrenal axis operates through a classic negative feedback loop: the hypothalamus releases CRH (corticotropin-releasing hormone) in response to stress signals, CRH drives pituitary ACTH (adrenocorticotropic hormone) release, and ACTH stimulates the adrenal cortex to produce cortisol. Cortisol then feeds back to suppress both hypothalamic CRH and pituitary ACTH, completing the loop. Under normal physiological conditions, this system operates with robust circadian rhythmicity: cortisol peaks within 30–45 minutes of waking (the Cortisol Awakening Response, CAR), declines throughout the day, and reaches its nadir around midnight.
The cortisol awakening response (CAR) is not simply a continuation of the nocturnal basal cortisol level — it is a distinct, anticipatory neural signal triggered by light exposure, the act of waking, and anticipatory cognitive activation. The CAR produces a 50–160% increase in cortisol within 30 minutes of waking that serves to mobilize glucose from glycogen stores, upregulate immune surveillance, prime cognitive function, and prepare the organism for the energetic demands of the day. A blunted or absent CAR is associated with burnout, chronic fatigue, depression, and HPA axis hyporesponsiveness. An exaggerated CAR is associated with high perceived psychological stress, anxiety, and HPA axis hyperresponsiveness.
Under chronic psychological, physiological, or metabolic stress, the HPA axis passes through recognizable stages. In the initial acute phase, cortisol rises appropriately in response to stressors. With sustained stress, cortisol may remain chronically elevated (often called “high cortisol phase”), driving the metabolic consequences of hypercortisolism: central adiposity, insulin resistance, immune suppression, hippocampal atrophy (the hippocampus is rich in glucocorticoid receptors and highly sensitive to cortisol excess), bone resorption, and reproductive axis suppression. In a subsequent phase — with prolonged and unremitting stress — the feedback sensitivity of the axis may shift toward hypocortisolism: reduced diurnal amplitude, blunted CAR, and low-normal total cortisol output, seen clinically in burnout, ME/CFS, and post-traumatic stress disorder.
DUTCH Testing: Why 24-Hour Urinary Hormone Metabolites Change Everything
The Dried Urine Test for Comprehensive Hormones (DUTCH Complete) measures steroid hormone metabolites in urine collected at four time points across a single day (morning, afternoon, evening, and bedtime), providing a comprehensive picture of cortisol production, metabolism, and circadian rhythm that no serum test can replicate. What DUTCH adds beyond serum or salivary cortisol:
Cortisol metabolites (THF, THE, a-THF, b-THF): These tetrahydrometabolites reflect total 24-hour cortisol production — the integrated output of the HPA axis — rather than the single instantaneous snapshot provided by a morning serum cortisol. A patient can have “normal” morning serum cortisol while producing either dramatically more or less total cortisol than optimal over the full 24-hour period. THF+THE and a-THF collectively assess both cortisol biosynthesis and 11-beta-HSD2 activity (the enzyme that inactivates cortisol to cortisone); elevated metabolites suggest increased HPA drive; reduced metabolites suggest HPA hyporesponsiveness.
Cortisone (free and metabolized): 11β-HSD1 in adipose and liver tissue converts cortisone back to active cortisol — this “pre-receptor” amplification means that a patient’s tissue cortisol exposure can substantially exceed what circulating cortisol levels suggest, particularly in obesity where 11β-HSD1 activity is upregulated. DUTCH metabolite patterns can reveal this tissue-level amplification, explaining why some obese patients show cortisol-driven metabolic pathology despite normal serum cortisol.
DHEA-S and DHEA metabolites (etiocholanolone, androsterone): DHEA-S is the most abundant circulating steroid in humans and the primary adrenal androgen precursor. The cortisol/DHEA ratio is a validated stress and aging biomarker; rising ratio reflects stress-driven HPA activation with declining DHEA production. DHEA metabolites on DUTCH also reveal androgen excess pathways relevant to PCOS (elevated androsterone), hirsutism, and androgen-driven conditions.
Estrogen metabolites and methylation: DUTCH provides the 2-OH, 4-OH, and 16α-OH estrogen metabolite ratios that assess estrogen detoxification pathways. The 2:16 ratio is a validated cancer risk marker (higher 2-OH:16α-OH associated with lower breast and cervical cancer risk). The methylation of 2-OH estradiol to 2-methoxy-estradiol (by COMT enzyme, requiring adequate SAM-e) determines whether estrogen metabolites are inactivated or remain biologically active. This methylation assessment directly reflects the functional status of MTHFR-SAM-e methylation capacity that cannot be inferred from genetics alone.
Melatonin and serotonin markers: DUTCH includes 6-hydroxymelatonin sulfate (the primary urinary melatonin metabolite) and 5-HIAA (5-hydroxyindoleacetic acid, the principal serotonin metabolite). Low melatonin output identifies patients with circadian disruption and explains chronic insomnia that is actually insufficient melatonin production rather than behavioral sleep issues. Low 5-HIAA correlates with serotonin deficiency states relevant to depression, anxiety, and carbohydrate craving.
The Cortisol-Thyroid Interaction: Why HPA Dysfunction Causes Hypothyroid Symptoms
One of the most clinically important but underappreciated interactions in functional endocrinology is the bidirectional relationship between HPA axis function and thyroid hormone metabolism. Chronically elevated cortisol — whether from external stress, poor sleep, blood sugar dysregulation, or chronic inflammation — impairs thyroid function through multiple converging mechanisms.
First, elevated cortisol inhibits pituitary TSH secretion, reducing the drive for thyroid hormone synthesis. Second, cortisol impairs the peripheral conversion of T4 (thyroxine, the largely inactive prohormone) to T3 (triiodothyronine, the biologically active form) by reducing type 1 deiodinase (DIO1) activity, while simultaneously increasing conversion to reverse T3 (rT3) — the metabolically inert isomer that competitively blocks T3 receptor binding. Third, elevated cortisol reduces thyroid hormone receptor sensitivity at the cellular level.
The clinical consequence is that a patient under chronic stress may present with classic hypothyroid symptoms — fatigue, cold intolerance, hair loss, constipation, weight gain, cognitive fog — while having normal TSH and T4. Measuring free T3 and reverse T3 reveals the impaired conversion, but the root cause is HPA axis dysregulation rather than thyroid pathology. Treating this with levothyroxine alone (adding more T4 substrate to an already-impaired conversion pathway) rarely resolves symptoms; addressing the HPA axis and reducing cortisol-driven rT3 production is the functional approach.
HPA Axis and Blood Sugar: The Adrenal-Metabolic Connection
Cortisol is a primary counter-regulatory hormone for blood sugar: it opposes insulin action, promotes hepatic gluconeogenesis, drives glycogen breakdown, and increases appetite — particularly for high-calorie, high-glycemic foods. This is why chronic HPA dysregulation is both a cause and consequence of metabolic syndrome. The mechanistic links are multiple and bidirectional.
Hypoglycemia (including reactive hypoglycemia after high-glycemic meals) is a potent stressor that activates the HPA axis, driving cortisol and adrenaline release — creating a feedback loop where blood sugar instability perpetually stresses the HPA axis. Conversely, chronically elevated cortisol drives visceral adiposity through multiple mechanisms (upregulation of lipoprotein lipase in visceral fat, reduced adiponectin, increased appetite for hyperpalatable foods) — and visceral adipose tissue itself is a source of inflammatory cytokines that further activate the HPA axis through IL-6 and TNF-α stimulation of the hypothalamus.
Breaking this cycle requires addressing both ends simultaneously: stabilizing blood sugar through low-glycemic dietary approaches (reducing reactive hypoglycemia-driven cortisol spikes) and reducing HPA activation through adaptogenic support, sleep optimization, and stress resilience strategies. This is why patients with chronic HPA dysregulation rarely improve with HPA-focused interventions alone if they continue consuming a high-glycemic diet that generates multiple daily blood sugar-driven cortisol pulses.
Adaptogens: The Evidence-Based HPA Support Category
Ashwagandha (Withania somnifera)
Ashwagandha is the most extensively studied adaptogen for HPA axis support, with the largest human RCT evidence base. Chandrasekhar and colleagues (2012, Indian Journal of Psychological Medicine) randomized 64 stressed adults to ashwagandha root extract (KSM-66, 300mg twice daily) or placebo for 60 days, finding significant reductions in Perceived Stress Scale scores (−44% vs. −5.5%), serum cortisol (−27.9% vs. −7.9%), and all measures of stress, anxiety, and wellbeing. A 2019 RCT by Salve and colleagues found KSM-66 ashwagandha 240mg/day for 60 days significantly reduced morning cortisol (−23%), serum creatine kinase (stress/exercise damage marker), and body weight compared to placebo. The primary mechanisms include withanolide glycosides binding to glucocorticoid receptors and modulating HPA axis feedback, reducing CRH-driven ACTH secretion.
Rhodiola rosea
Rhodiola rosea — an adaptogen from high-altitude regions of Eurasia — has demonstrated efficacy for stress-related fatigue and cognitive performance in multiple RCTs. Shevtsov and colleagues (2003, Phytomedicine) found standardized rhodiola extract (SHR-5, 370mg/day) significantly improved mental performance, psychomotor function, and mental fatigue in night-shift physicians over 6 weeks versus placebo. Darbinyan and colleagues (2000, Phytomedicine) found similar benefits in military cadets during examination stress. The active compounds (rosavins and salidroside) appear to modulate HPA axis activation through Hsp70 and nitric oxide pathways, and inhibit stress-induced degradation of catecholamines by monoamine oxidase.
Phosphatidylserine
Phosphatidylserine (PS) — a phospholipid component of neural membranes — blunts exercise-induced and psychological stress-induced cortisol and ACTH responses in RCTs. Monteleone and colleagues (1990, Neuroendocrinology) showed that 800mg/day of bovine brain PS significantly reduced ACTH and cortisol responses to physical stress. Subsequent trials with soy-derived PS (400–800mg/day) confirmed cortisol-blunting effects during physical and cognitive stress. PS appears to suppress HPA axis activation specifically at the level of hypothalamic CRH release, providing targeted dampening of excessive HPA reactivity without broadly suppressing the stress response.
DHEA Supplementation: Evidence and Clinical Use
DHEA (dehydroepiandrosterone) and its sulfated form DHEA-S — produced primarily by the adrenal zona reticularis — are the most abundant circulating steroids in humans and serve as precursors to both testosterone and estradiol via peripheral conversion in target tissues. DHEA levels peak in the mid-20s and decline approximately 2% per year; by age 70, levels are typically 80% lower than at their peak. This decline is so reliable that DHEA-S is used as a proxy for adrenal androgenic function in clinical assessment.
The Rancho Bernardo cohort study (Barrett-Connor 1986, NEJM) established the landmark association between DHEA-S and mortality. The InCHIANTI, NAHNES, and multiple subsequent cohort studies have confirmed inverse associations between DHEA-S and cardiovascular disease, metabolic syndrome, cognitive decline, depression, and bone loss. DHEA’s protective effects appear to operate through multiple mechanisms: anti-insulin resistance effects (opposing cortisol’s gluconeogenic and insulin-desensitizing actions), direct immunomodulatory effects (promoting Th1 immune responses and natural killer cell activity), bone protective effects (providing androgenic substrate for osteoblast function), and neuroprotective effects (including sigma-1 receptor activity and neurosteroid activity).
Clinical DHEA supplementation (25–50mg/day in women; 50–100mg/day in men) is typically guided by DHEA-S measurement, with targets in the upper quartile of the age-appropriate reference range rather than the broad population range. Key clinical considerations include aromatization to estradiol in adipose tissue (monitoring estradiol in obese individuals), androgenic effects in women (monitoring DHEA-S and clinical signs of androgen excess), and the observation that optimizing upstream HPA axis function — through sleep, stress management, and metabolic health — can meaningfully restore DHEA-S endogenously, reducing the need for exogenous supplementation.
Frequently Asked Questions About Functional HPA Axis Assessment
What is “adrenal fatigue” and is it real?
“Adrenal fatigue” as traditionally described — the idea that the adrenal glands become exhausted and stop producing cortisol — is not a recognized physiological mechanism. True adrenal insufficiency (Addison’s disease, secondary adrenal insufficiency) involves measurable adrenal cortical destruction or ACTH deficiency and requires pharmaceutical cortisol replacement. What functional medicine describes as “HPA axis dysregulation” is real and measurable, but involves altered hypothalamic-pituitary sensitivity, feedback regulation changes, and circadian rhythm disruption — not adrenal gland exhaustion. DUTCH testing can document these patterns (blunted CAR, flattened diurnal slope, reduced total cortisol metabolites) even when morning serum cortisol is “normal.”
How does poor sleep affect cortisol?
Sleep deprivation produces measurable HPA axis dysregulation within 24–48 hours. Even one night of poor sleep elevates evening cortisol (normally at its nadir), disrupts the CAR, and elevates overnight cortisol in the hours when growth hormone is supposed to dominate. Chronic sleep deprivation shifts the entire diurnal cortisol curve toward evening elevation, driving the visceral adiposity, insulin resistance, and appetite dysregulation characteristic of metabolic syndrome. Improving sleep quality and duration is one of the most effective HPA axis interventions available — more powerful than any adaptogen when sleep deficiency is the primary driver.
Can exercise help or hurt the HPA axis?
Both, depending on dose and individual resilience. Moderate aerobic exercise (Zone 2 intensity) is anti-inflammatory, improves HPA axis feedback sensitivity, reduces basal cortisol in overtraining states, and improves sleep quality — all beneficial for HPA function. High-intensity training performed excessively relative to recovery capacity elevates cortisol, suppresses testosterone, impairs immune function, and drives the overtraining syndrome that produces HPA dysregulation indistinguishable from burnout. Exercise should be periodized with adequate recovery, and DUTCH testing can help athletes understand whether their training load is producing adaptive vs. maladaptive HPA responses.
What is the cortisol awakening response (CAR) and why does it matter?
The CAR — the 50–160% rise in cortisol within 30 minutes of waking — reflects the HPA axis’s morning mobilization capacity. Research shows the CAR is reduced in burnout, major depression, chronic fatigue syndrome, and PTSD — indicating a hyporesponsive HPA axis with insufficient morning activation. A blunted CAR predicts poor concentration, fatigue through the day, impaired immune surveillance, and risk of workplace errors in demanding roles. Strategies to restore CAR include: bright light exposure immediately upon waking (activating the suprachiasmatic nucleus), morning cold exposure (driving sympathetic activation), morning physical movement, and stable sleep-wake scheduling.
Restoring HPA Axis Resilience: The Comprehensive Protocol
HPA axis restoration is one of the highest-leverage interventions in functional medicine because the HPA axis regulates so many downstream systems simultaneously. The protocol typically includes: sleep optimization (7–9 hours, consistent sleep-wake times, dark/cool sleep environment); blood sugar stabilization (eliminating reactive hypoglycemia through low-glycemic dietary patterns and adequate protein at each meal); exercise periodization (Zone 2 aerobic training with adequate recovery); targeted adaptogenic support (ashwagandha and/or rhodiola based on DUTCH pattern — high-cortisol patterns vs. low-cortisol patterns require different approaches); anti-inflammatory nutrition (reducing IL-6/TNF-α driven CRH stimulation); and — where indicated — DHEA replacement to restore physiological DHEA-S levels and the cortisol/DHEA balance.
If you are experiencing persistent fatigue, sleep dysregulation, burnout symptoms, unexplained weight changes, hormonal imbalances, or mood instability that hasn’t resolved with standard treatments, a comprehensive DUTCH hormone evaluation can reveal the specific HPA axis pattern driving your symptoms and direct a targeted restoration protocol. To schedule your functional endocrinology evaluation at The Private Practice, call (810) 206-1402.